These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37051250)

  • 1. Perfluorocarbon nanodrug induced oxygen self-enriching sonodynamic therapy improves cancer immunotherapy after insufficient radiofrequency ablation.
    Huang T; Wu W; Wu J; Tan Y; Zhang M; Long H; Guo H; Zhang X; Zhou W; Zhang Q; Xie X; Xu M; Zhang C
    Front Immunol; 2023; 14():1124152. PubMed ID: 37051250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.
    Lin X; Huang R; Huang Y; Wang K; Li H; Bao Y; Wu C; Zhang Y; Tian X; Wang X
    Int J Nanomedicine; 2021; 16():1889-1899. PubMed ID: 33707944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanodroplet-enhanced sonodynamic therapy potentiates immune checkpoint blockade for systemic suppression of triple-negative breast cancer.
    Wu W; Xu M; Qiao B; Huang T; Guo H; Zhang N; Zhou L; Li M; Tan Y; Zhang M; Xie X; Shuai X; Zhang C
    Acta Biomater; 2023 Mar; 158():547-559. PubMed ID: 36539109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
    Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
    Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of OK-432 in combination with an anti-PD-1 antibody for residual tumors after radiofrequency ablation of hepatocellular carcinoma.
    Sun T; Sun B; Cao Y; Liu J; Chen J; Liang B; Zheng C; Kan X
    Biomed Pharmacother; 2023 Oct; 166():115351. PubMed ID: 37625323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TiSe
    Chen L; Xue W; Cao J; Zhang S; Zeng Y; Ma L; Qian X; Wen Q; Hong Y; Shi Z; Xu Y
    J Nanobiotechnology; 2022 Oct; 20(1):453. PubMed ID: 36243711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancer.
    Wan G; Chen X; Wang H; Hou S; Wang Q; Cheng Y; Chen Q; Lv Y; Chen H; Zhang Q
    J Nanobiotechnology; 2021 Oct; 19(1):347. PubMed ID: 34715867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase-Transformation Nanoparticle-Mediated Sonodynamic Therapy: An Effective Modality to Enhance Anti-Tumor Immune Response by Inducing Immunogenic Cell Death in Breast Cancer.
    Si Y; Yue J; Liu Z; Li M; Du F; Wang X; Dai Z; Hu N; Ju J; Gao S; Wang X; Yuan P
    Int J Nanomedicine; 2021; 16():1913-1926. PubMed ID: 33707946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanobubble-mediated co-delivery of Ce6 and miR-195 for synergized sonodynamic and checkpoint blockade combination therapy with elicitation of robust immune response in hepatocellular carcinoma.
    Ma Y; Li J; Zhao Y; Hu B; Liu Y; Liu C
    Eur J Pharm Biopharm; 2022 Dec; 181():36-48. PubMed ID: 36307001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation.
    Ji C; Si J; Xu Y; Zhang W; Yang Y; He X; Xu H; Mou X; Ren H; Guo H
    Theranostics; 2021; 11(17):8587-8604. PubMed ID: 34373760
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeting PI3Kγ/AKT Pathway Remodels LC3-Associated Phagocytosis Induced Immunosuppression After Radiofrequency Ablation.
    Liu X; Zhang W; Xu Y; Xu X; Jiang Q; Ruan J; Wu Y; Zhou Y; Saw PE; Luo B
    Adv Sci (Weinh); 2022 Mar; 9(7):e2102182. PubMed ID: 35037422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA.
    Zhang S; Huang Y; Pi S; Chen H; Ye F; Wu C; Li L; Ye Q; Lin Y; Su Z
    J Nanobiotechnology; 2023 Oct; 21(1):360. PubMed ID: 37789342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy.
    Shi L; Wang J; Ding N; Zhang Y; Zhu Y; Dong S; Wang X; Peng C; Zhou C; Zhou L; Li X; Shi H; Wu W; Long X; Wu C; Liao W
    Nat Commun; 2019 Nov; 10(1):5421. PubMed ID: 31780645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sonosensitizer nanoplatform-mediated sonodynamic therapy induced immunogenic cell death and tumor immune microenvironment variation.
    Zheng J; Sun Y; Long T; Yuan D; Yue S; Zhang N; Yang Z
    Drug Deliv; 2022 Dec; 29(1):1164-1175. PubMed ID: 35393920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity.
    Wang T; Peng W; Du M; Chen Z
    Front Oncol; 2023; 13():1167105. PubMed ID: 37168380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma.
    Liu J; Li X; Chen J; Guo J; Guo H; Zhang X; Fan J; Zhang K; Mao J; Zhou B
    J Nanobiotechnology; 2024 Jun; 22(1):338. PubMed ID: 38890737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focused acoustic vortex-mediated sonochemotherapy for the amplification of immunogenic cell death combined with checkpoint blockade to potentiate cancer immunotherapy.
    Ya Z; Guo S; Li Y; Zhu M; Zhang L; Zong Y; Wan M
    Biomaterials; 2023 Oct; 301():122278. PubMed ID: 37598439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice.
    Tan Y; Yang S; Ma Y; Li J; Xie Q; Liu C; Zhao Y
    Int J Nanomedicine; 2021; 16():3241-3254. PubMed ID: 34007176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy.
    Huang J; Xiao Z; An Y; Han S; Wu W; Wang Y; Guo Y; Shuai X
    Biomaterials; 2021 Feb; 269():120636. PubMed ID: 33453632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.